BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

391 related articles for article (PubMed ID: 23560052)

  • 1. Neuroinflammation and neuronal loss precede Aβ plaque deposition in the hAPP-J20 mouse model of Alzheimer's disease.
    Wright AL; Zinn R; Hohensinn B; Konen LM; Beynon SB; Tan RP; Clark IA; Abdipranoto A; Vissel B
    PLoS One; 2013; 8(4):e59586. PubMed ID: 23560052
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Time Course of Recognition Memory Impairment and Glial Pathology in the hAPP-J20 Mouse Model of Alzheimer's Disease.
    Ameen-Ali KE; Simpson JE; Wharton SB; Heath PR; Sharp PS; Brezzo G; Berwick J
    J Alzheimers Dis; 2019; 68(2):609-624. PubMed ID: 30814360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amyloid-β plaque formation and reactive gliosis are required for induction of cognitive deficits in App knock-in mouse models of Alzheimer's disease.
    Sakakibara Y; Sekiya M; Saito T; Saido TC; Iijima KM
    BMC Neurosci; 2019 Mar; 20(1):13. PubMed ID: 30894120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Whole-body vibration ameliorates glial pathological changes in the hippocampus of hAPP transgenic mice, but does not affect plaque load.
    Oroszi T; Geerts E; Rajadhyaksha R; Nyakas C; van Heuvelen MJG; van der Zee EA
    Behav Brain Funct; 2023 Mar; 19(1):5. PubMed ID: 36941713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stereological estimation of neuron number and plaque load in the hippocampal region of a transgenic rat model of Alzheimer's disease.
    Heggland I; Storkaas IS; Soligard HT; Kobro-Flatmoen A; Witter MP
    Eur J Neurosci; 2015 May; 41(9):1245-62. PubMed ID: 25808554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deletion of Abca7 increases cerebral amyloid-β accumulation in the J20 mouse model of Alzheimer's disease.
    Kim WS; Li H; Ruberu K; Chan S; Elliott DA; Low JK; Cheng D; Karl T; Garner B
    J Neurosci; 2013 Mar; 33(10):4387-94. PubMed ID: 23467355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of Transgenic Metallothionein-1 on Gliosis, CA1 Neuronal Loss, and Brain Metal Levels of the Tg2576 Mouse Model of Alzheimer's Disease.
    Comes G; Manso Y; Escrig A; Fernandez-Gayol O; Sanchis P; Molinero A; Giralt M; Carrasco J; Hidalgo J
    Int J Mol Sci; 2017 Jan; 18(2):. PubMed ID: 28134760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-Aβ antibodies bound to neuritic plaques enhance microglia activity and mitigate tau pathology.
    Laversenne V; Nazeeruddin S; Källstig EC; Colin P; Voize C; Schneider BL
    Acta Neuropathol Commun; 2020 Nov; 8(1):198. PubMed ID: 33225991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of human S100B exacerbates cerebral amyloidosis and gliosis in the Tg2576 mouse model of Alzheimer's disease.
    Mori T; Koyama N; Arendash GW; Horikoshi-Sakuraba Y; Tan J; Town T
    Glia; 2010 Feb; 58(3):300-14. PubMed ID: 19705461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CB2 receptor deficiency increases amyloid pathology and alters tau processing in a transgenic mouse model of Alzheimer's disease.
    Koppel J; Vingtdeux V; Marambaud P; d'Abramo C; Jimenez H; Stauber M; Friedman R; Davies P
    Mol Med; 2014 Mar; 20(1):29-36. PubMed ID: 24722782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibrillar Aβ triggers microglial proteome alterations and dysfunction in Alzheimer mouse models.
    Sebastian Monasor L; Müller SA; Colombo AV; Tanrioever G; König J; Roth S; Liesz A; Berghofer A; Piechotta A; Prestel M; Saito T; Saido TC; Herms J; Willem M; Haass C; Lichtenthaler SF; Tahirovic S
    Elife; 2020 Jun; 9():. PubMed ID: 32510331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complement C3 deficiency leads to accelerated amyloid beta plaque deposition and neurodegeneration and modulation of the microglia/macrophage phenotype in amyloid precursor protein transgenic mice.
    Maier M; Peng Y; Jiang L; Seabrook TJ; Carroll MC; Lemere CA
    J Neurosci; 2008 Jun; 28(25):6333-41. PubMed ID: 18562603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early fear memory defects are associated with altered synaptic plasticity and molecular architecture in the TgCRND8 Alzheimer's disease mouse model.
    Steele JW; Brautigam H; Short JA; Sowa A; Shi M; Yadav A; Weaver CM; Westaway D; Fraser PE; St George-Hyslop PH; Gandy S; Hof PR; Dickstein DL
    J Comp Neurol; 2014 Jul; 522(10):2319-35. PubMed ID: 24415002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interferon-gamma and tumor necrosis factor-alpha regulate amyloid-beta plaque deposition and beta-secretase expression in Swedish mutant APP transgenic mice.
    Yamamoto M; Kiyota T; Horiba M; Buescher JL; Walsh SM; Gendelman HE; Ikezu T
    Am J Pathol; 2007 Feb; 170(2):680-92. PubMed ID: 17255335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ablating ErbB4 in PV neurons attenuates synaptic and cognitive deficits in an animal model of Alzheimer's disease.
    Zhang H; Zhang L; Zhou D; He X; Wang D; Pan H; Zhang X; Mei Y; Qian Q; Zheng T; Jones FE; Sun B
    Neurobiol Dis; 2017 Oct; 106():171-180. PubMed ID: 28684271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuronal Protein Tyrosine Phosphatase 1B Hastens Amyloid β-Associated Alzheimer's Disease in Mice.
    Ricke KM; Cruz SA; Qin Z; Farrokhi K; Sharmin F; Zhang L; Zasloff MA; Stewart AFR; Chen HH
    J Neurosci; 2020 Feb; 40(7):1581-1593. PubMed ID: 31915254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Presubiculum principal cells are preserved from degeneration in knock-in APP/TAU mouse models of Alzheimer's disease.
    Islam A; Saito T; Saido T; Ali AB
    Semin Cell Dev Biol; 2023 Apr; 139():55-72. PubMed ID: 35292192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BACE1 elevation is involved in amyloid plaque development in the triple transgenic model of Alzheimer's disease: differential Aβ antibody labeling of early-onset axon terminal pathology.
    Cai Y; Zhang XM; Macklin LN; Cai H; Luo XG; Oddo S; Laferla FM; Struble RG; Rose GM; Patrylo PR; Yan XX
    Neurotox Res; 2012 Feb; 21(2):160-74. PubMed ID: 21725719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NFATc2 Modulates Microglial Activation in the AβPP/PS1 Mouse Model of Alzheimer's Disease.
    Manocha GD; Ghatak A; Puig KL; Kraner SD; Norris CM; Combs CK
    J Alzheimers Dis; 2017; 58(3):775-787. PubMed ID: 28505967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuronal and glial alterations, increased anxiety, and cognitive impairment before hippocampal amyloid deposition in PDAPP mice, model of Alzheimer's disease.
    Beauquis J; Vinuesa A; Pomilio C; Pavía P; Galván V; Saravia F
    Hippocampus; 2014 Mar; 24(3):257-69. PubMed ID: 24132937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.